Xenon Pharmaceuticals Inc.
XENE
$55.00
-$0.78-1.40%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.09B | 548.89M | 462.27M | 487.55M | 549.63M |
| Total Receivables | 1.17M | 1.37M | 812.00K | 1.10M | 8.65M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.72M | 10.39M | 17.06M | 11.61M | 7.26M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.11B | 560.65M | 480.14M | 500.25M | 565.54M |
|
|
|||||
| Total Current Assets | 1.11B | 560.65M | 480.14M | 500.25M | 565.54M |
| Net Property, Plant & Equipment | 14.58M | 15.35M | 15.85M | 16.50M | 17.31M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 20.72M | 20.02M | 18.86M | 20.24M | 18.93M |
| Total Assets | 1.39B | 633.16M | 607.84M | 674.28M | 743.28M |
|
|
|||||
| Total Accounts Payable | 5.75M | 3.89M | 4.55M | 4.79M | 6.88M |
| Total Accrued Expenses | 32.24M | 36.06M | 32.06M | 24.97M | 16.76M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.56M | 1.53M | 1.50M | 1.46M | 1.38M |
| Total Finance Division Other Current Liabilities | 269.00K | 313.00K | 231.00K | 1.83M | 7.01M |
| Total Other Current Liabilities | 269.00K | 313.00K | 231.00K | 1.83M | 7.01M |
| Total Current Liabilities | 39.82M | 41.79M | 38.34M | 33.05M | 32.03M |
|
|
|||||
| Total Current Liabilities | 39.82M | 41.79M | 38.34M | 33.05M | 32.03M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.93M | 6.41M | 6.83M | 7.26M | 7.29M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.25M | 3.20M | 3.16M | -- | -- |
| Total Liabilities | 48.99M | 51.40M | 48.33M | 40.30M | 39.32M |
|
|
|||||
| Common Stock & APIC | 2.69B | 1.83B | 1.70B | 1.68B | 1.67B |
| Retained Earnings | -1.35B | -1.25B | -1.14B | -1.05B | -964.52M |
| Treasury Stock & Other | -1.21M | 335.00K | 477.00K | 113.00K | -836.00K |
| Total Common Equity | 1.34B | 581.76M | 559.51M | 633.98M | 703.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.34B | 581.76M | 559.51M | 633.98M | 703.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.34B | 581.76M | 559.51M | 633.98M | 703.96M |
|
|
|||||